rs121964961
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000532.5(PCCB):āc.1304A>Gā(p.Tyr435Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000085 in 1,612,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_000532.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCCB | NM_000532.5 | c.1304A>G | p.Tyr435Cys | missense_variant | 13/15 | ENST00000251654.9 | NP_000523.2 | |
PCCB | NM_001178014.2 | c.1364A>G | p.Tyr455Cys | missense_variant | 14/16 | NP_001171485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCCB | ENST00000251654.9 | c.1304A>G | p.Tyr435Cys | missense_variant | 13/15 | 1 | NM_000532.5 | ENSP00000251654 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251316Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135830
GnomAD4 exome AF: 0.0000884 AC: 129AN: 1460092Hom.: 0 Cov.: 31 AF XY: 0.0000743 AC XY: 54AN XY: 726520
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74448
ClinVar
Submissions by phenotype
Propionic acidemia Pathogenic:9Other:1
Likely pathogenic, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 29, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2002 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 435 of the PCCB protein (p.Tyr435Cys). This variant is present in population databases (rs121964961, gnomAD 0.06%). This missense change has been observed in individuals with propionic acidemia (PMID: 12189489). ClinVar contains an entry for this variant (Variation ID: 12018). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PCCB protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 05, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 20, 2017 | Variant summary: The PCCB c.1304A>G (p.Tyr435Cys) variant located in the CoA carboxyltransferase C-terminal domain (via InterPro) involves the alteration of a conserved nucleotide and is predicted to be damaging by 5/5 in silico tools. This variant was found in 8/121510 control chromosomes including broad and large populations from ExAC at a heterozygous allele frequency of 0.0000658, which does not exceed the estimated maximal expected allele frequency of a pathogenic PCCB variant (0.0025). This variant is known to be a common pathogenic variant that causes mild propionic academia in Japanese population (Yorifuji_2002). The carrier frequency of this variant in Japanese population was estimated to be 1/86.5 by the authors. Enzymatic activity in peripheral blood leukocytes of patients carrying this variant in homozygous state or compound heterozygous state revealed significantly reduced but residual activity consistent with the phenotype caused (Yorifuji_2002). It was not found in a cohort of 30 patients with more severe form of disease in the same population (Yang_2004). Multiple reputable databases and the publications have classified this variant as pathogenic. Taken together, this variant is classified as Pathogenic. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | Apr 17, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Intergen, Intergen Genetics and Rare Diseases Diagnosis Center | Jul 12, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at